A case of delayed detection of vertical transmission of HIV-1 due to maternal therapy with long-acting injectable cabotegravir plus rilpivirine.

Feiterna-Sperling, Cornelia; Albers, Eva; Rohr, Irena; Weizsäcker, Katharina; Menner, Nikolai; Bührer, Christoph; Corman, Victor Max; Obermeier, Martin et al. · Clin Infect Dis · 2026

case_report · Level V

Where this comes from

Record sourced from PubMed, PMID 42047432.
Also identified by DOI 10.1093/cid/ciag290.
No licence information is recorded for this record.
Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.

Abstract

We report on a 4-month-old infant with delayed HIV-1 diagnosis after maternal antiretroviral therapy with long-acting injectable cabotegravir plus rilpivirine (LA-CAB/RPV) in the third trimester. Prolonged viral suppression in HIV-infected infants exposed to maternal LA-CAB/RPV may necessitate molecular testing beyond three months of age to exclude infection.

Read the full text

View on PubMed · Publisher (DOI)